|
Consolidated Statements of Operations (USD $)
|
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
| Consolidated Statements of Operations [Abstract] | |||
| Fee income | $ 2,161,359 | $ 1,957,336 | $ 845,982 |
| Operating expenses | 5,841,268 | 3,995,633 | 3,618,635 |
| Research and development | 2,203,326 | 1,671,872 | 1,390,689 |
| Total expenses | 8,044,594 | 5,667,505 | 5,009,324 |
| Operating loss | (5,883,235) | (3,710,169) | (4,163,342) |
| Net investment income | 38,148 | 33,171 | 29,274 |
| Loss before income tax benefit | (5,845,087) | (3,676,998) | (4,134,068) |
| Income tax benefit | 613,397 | ||
| Net loss | $ (5,845,087) | $ (3,063,601) | $ (4,134,068) |
| Basic and diluted net loss per common share | $ (0.25) | $ (0.15) | $ (0.22) |
| Basic and diluted weighted average number of common shares outstanding | 22,946,019 | 20,125,309 | 18,538,041 |